These results suggest that ApoA5 deficiency causes hypertriglyceridemia by impairing exogenous TG clearance in circulation, enhancing endogenous TG synthesis and secretion by liver, and reducing the storage capacity of adipose tissue. Here, APOA5 is linked to hypertriglyceridemia.